The variables selected included APACHE II score, CMV IgG level, history of organ transplantation, chronic kidney disease (CKD), CD4+ lymphocyte count, and the number of days of intravenous corticosteroid use within 28 days. This evidence concerns the gene CD4 and chronic kidney disease.